Ewa, LLC Tiziana Life Sciences LTD Call Options Transaction History
Ewa, LLC
- $266 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TLSA
# of Institutions
31Shares Held
992KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA246KShares$191,6630.0% of portfolio
-
Morgan Stanley New York, NY111KShares$86,4480.0% of portfolio
-
Hsbc Holdings PLC London, X0105KShares$82,1840.0% of portfolio
-
Zhang Financial LLC93.2KShares$72,6850.0% of portfolio
-
Kovitz Investment Group Partners, LLC79.4KShares$61,9040.0% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $79.8M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...